As of 2025-05-17, the EV/EBITDA ratio of Bioatla Inc (BCAB) is 0.35. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Bioatla's latest enterprise value is -25.67 mil USD. Bioatla's TTM EBITDA according to its financial statements is -73.03 mil USD. Dividing these 2 quantities gives us the above Bioatla EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 13.5x | 13.4x |
| Forward P/E multiples | 19.0x - 32.5x | 25.8x |
| Fair Price | (22.91) - (16.04) | (23.63) |
| Upside | -5824.9% - -4107.0% | -6004.5% |
| Date | EV/EBITDA |
| 2025-05-05 | 0.26 |
| 2025-05-02 | 0.23 |
| 2025-05-01 | 0.27 |
| 2025-04-30 | 0.28 |
| 2025-04-29 | 0.28 |
| 2025-04-28 | 0.32 |
| 2025-04-25 | 0.32 |
| 2025-04-24 | 0.31 |
| 2025-04-23 | 0.37 |
| 2025-04-22 | 0.39 |
| 2025-04-21 | 0.40 |
| 2025-04-17 | 0.41 |
| 2025-04-16 | 0.42 |
| 2025-04-15 | 0.42 |
| 2025-04-14 | 0.42 |
| 2025-04-11 | 0.43 |
| 2025-04-10 | 0.44 |
| 2025-04-09 | 0.43 |
| 2025-04-08 | 0.46 |
| 2025-04-07 | 0.44 |
| 2025-04-04 | 0.45 |
| 2025-04-03 | 0.43 |
| 2025-04-02 | 0.40 |
| 2025-04-01 | 0.39 |
| 2025-03-31 | 0.39 |
| 2025-03-28 | 0.37 |
| 2025-03-27 | 0.36 |
| 2025-03-26 | 0.37 |
| 2025-03-25 | 0.38 |
| 2025-03-24 | 0.38 |
| 2025-03-21 | 0.39 |
| 2025-03-20 | 0.38 |
| 2025-03-19 | 0.39 |
| 2025-03-18 | 0.39 |
| 2025-03-17 | 0.38 |
| 2025-03-14 | 0.40 |
| 2025-03-13 | 0.41 |
| 2025-03-12 | 0.40 |
| 2025-03-11 | 0.43 |
| 2025-03-10 | 0.42 |
| 2025-03-07 | 0.40 |
| 2025-03-06 | 0.41 |
| 2025-03-05 | 0.39 |
| 2025-03-04 | 0.42 |
| 2025-03-03 | 0.43 |
| 2025-02-28 | 0.41 |
| 2025-02-27 | 0.42 |
| 2025-02-26 | 0.40 |
| 2025-02-25 | 0.40 |
| 2025-02-24 | 0.37 |